AstraZeneca partners with Rigel on asthma drug – CBS News

AstraZeneca partners with Rigel on asthma drug
CBS News
NEW YORK — Rigel Pharmaceuticals Inc. plans to work with AstraZeneca PLC to develop an experimental asthma drug as part of a deal that could be worth
AstraZeneca and Rigel strike asthma deal worth up to $100MFierceBiotech
AstraZeneca And Rigel Sign Worldwide License Agreement For A MarketWatch (press release)
AstraZeneca, Rigel to Develop Asthma TreatmentNASDAQ
Bizjournals.com (blog)
all 22 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.